Literature DB >> 26512942

Altered Machinery of Protein Synthesis in Alzheimer's: From the Nucleolus to the Ribosome.

Karina Hernández-Ortega1,2, Paula Garcia-Esparcia1,2, Laura Gil3, José J Lucas2,4, Isidre Ferrer1,2.   

Abstract

Ribosomes and protein synthesis have been reported to be altered in the cerebral cortex at advanced stages of Alzheimer's disease (AD). Modifications in the hippocampus with disease progression have not been assessed. Sixty-seven cases including middle-aged (MA) and AD stages I-VI were analyzed. Nucleolar chaperones nucleolin, nucleophosmin and nucleoplasmin 3, and upstream binding transcription factor RNA polymerase I gene (UBTF) mRNAs are abnormally regulated and their protein levels reduced in AD. Histone modifications dimethylated histone H3K9 (H3K9me2) and acetylated histone H3K12 (H3K12ac) are decreased in CA1. Nuclear tau declines in CA1 and dentate gyrus (DG), and practically disappears in neurons with neurofibrillary tangles. Subunit 28 ribosomal RNA (28S rRNA) expression is altered in CA1 and DG in AD. Several genes encoding ribosomal proteins are abnormally regulated and protein levels of translation initiation factors eIF2α, eIF3η and eIF5, and elongation factor eEF2, are altered in the CA1 region in AD. These findings show alterations in the protein synthesis machinery in AD involving the nucleolus, nucleus and ribosomes in the hippocampus in AD some of them starting at first stages (I-II) preceding neuron loss. These changes may lie behind reduced numbers of dendritic branches and reduced synapses of CA1 and DG neurons which cause hippocampal atrophy.
© 2015 International Society of Neuropathology.

Entities:  

Keywords:  Alzheimer's disease; elongation factors of protein synthesis; histones; initiation factors; nuclear tau; nucleolin; nucleolus; nucleophosmin; nucleoplasmin; nucleus; protein synthesis; ribosomal proteins; ribosome; upstream binding transcription factor RNA polymerase I

Mesh:

Substances:

Year:  2015        PMID: 26512942     DOI: 10.1111/bpa.12335

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  61 in total

1.  Formaldehyde, Epigenetics, and Alzheimer's Disease.

Authors:  Fei Wang; Danqi Chen; Peipei Wu; Catherine Klein; Chunyuan Jin
Journal:  Chem Res Toxicol       Date:  2019-04-19       Impact factor: 3.739

2.  Increased Tau Phosphorylation in Motor Neurons From Clinically Pure Sporadic Amyotrophic Lateral Sclerosis Patients.

Authors:  Claire H Stevens; Natalie J Guthrie; Marloes van Roijen; Glenda M Halliday; Lezanne Ooi
Journal:  J Neuropathol Exp Neurol       Date:  2019-07-01       Impact factor: 3.685

Review 3.  Vitamins Associated with Brain Aging, Mild Cognitive Impairment, and Alzheimer Disease: Biomarkers, Epidemiological and Experimental Evidence, Plausible Mechanisms, and Knowledge Gaps.

Authors:  Michael Fenech
Journal:  Adv Nutr       Date:  2017-11-15       Impact factor: 8.701

4.  Altered mechanisms of protein synthesis in frontal cortex in Alzheimer disease and a mouse model.

Authors:  Paula Garcia-Esparcia; Georgios Sideris-Lampretsas; Karina Hernandez-Ortega; Oriol Grau-Rivera; Theodoros Sklaviadis; Ellen Gelpi; Isidro Ferrer
Journal:  Am J Neurodegener Dis       Date:  2017-06-15

Review 5.  Roles of tau protein in health and disease.

Authors:  Tong Guo; Wendy Noble; Diane P Hanger
Journal:  Acta Neuropathol       Date:  2017-04-06       Impact factor: 17.088

Review 6.  Ribosomopathies: Old Concepts, New Controversies.

Authors:  Katherine I Farley-Barnes; Lisa M Ogawa; Susan J Baserga
Journal:  Trends Genet       Date:  2019-07-31       Impact factor: 11.639

7.  Upregulation of Proteolytic Pathways and Altered Protein Biosynthesis Underlie Retinal Pathology in a Mouse Model of Alzheimer's Disease.

Authors:  Mehdi Mirzaei; Kanishka Pushpitha; Liting Deng; Nitin Chitranshi; Veer Gupta; Rashi Rajput; Abu Bakr Mangani; Yogita Dheer; Angela Godinez; Matthew J McKay; Karthik Kamath; Dana Pascovici; Jemma X Wu; Ghasem Hosseini Salekdeh; Tim Karl; Paul A Haynes; Stuart L Graham; Vivek K Gupta
Journal:  Mol Neurobiol       Date:  2019-02-01       Impact factor: 5.590

8.  Inhibition of EHMT1/2 rescues synaptic and cognitive functions for Alzheimer's disease.

Authors:  Yan Zheng; Aiyi Liu; Zi-Jun Wang; Qing Cao; Wei Wang; Lin Lin; Kaijie Ma; Freddy Zhang; Jing Wei; Emmanuel Matas; Jia Cheng; Guo-Jun Chen; Xiaomin Wang; Zhen Yan
Journal:  Brain       Date:  2019-03-01       Impact factor: 13.501

9.  Genetic reduction of eEF2 kinase alleviates pathophysiology in Alzheimer's disease model mice.

Authors:  Brenna C Beckelman; Wenzhong Yang; Nicole P Kasica; Helena R Zimmermann; Xueyan Zhou; C Dirk Keene; Alexey G Ryazanov; Tao Ma
Journal:  J Clin Invest       Date:  2019-01-22       Impact factor: 14.808

Review 10.  Tau-mediated dysregulation of RNA: Evidence for a common molecular mechanism of toxicity in frontotemporal dementia and other tauopathies.

Authors:  Shon A Koren; Sara Galvis-Escobar; Jose F Abisambra
Journal:  Neurobiol Dis       Date:  2020-05-12       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.